Evidence map›Paper›PMID 36658566›Full record

ArticleMicrobial cell factories2023

Increasing cellular fitness and product yields in Pseudomonas putida through an engineered phosphoketolase shunt.

Lyon Bruinsma, Maria Martin-Pascual, Kesi Kurnia, Marieken Tack, Simon Hendriks, Richard van Kranenburg, Vitor A P Martins Dos Santos

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Multi-layered metabolic remodeling ofMetabolic engineering communications · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Lyon BruinsmaLaboratory of Systems and Synthetic Biology, Wageningen University & Research, 6708 WE, Wageningen, The Netherlands.
Maria Martin-PascualLaboratory of Systems and Synthetic Biology, Wageningen University & Research, 6708 WE, Wageningen, The Netherlands.
Kesi KurniaLaboratory of Systems and Synthetic Biology, Wageningen University & Research, 6708 WE, Wageningen, The Netherlands.
Marieken TackLaboratory of Systems and Synthetic Biology, Wageningen University & Research, 6708 WE, Wageningen, The Netherlands.
Simon HendriksLaboratory of Systems and Synthetic Biology, Wageningen University & Research, 6708 WE, Wageningen, The Netherlands.
Richard van KranenburgCorbion, 4206 AC, Gorinchem, The Netherlands.
Vitor A P Martins Dos SantosLaboratory of Systems and Synthetic Biology, Wageningen University & Research, 6708 WE, Wageningen, The Netherlands. vitor.martinsdossantos@wur.nl.
Wageningen University & Research · NLLifeGlimmer (Germany) · DE

Funding

European Commission grant agreement Nos. 635536 (EmPowerPutida) and 730976 (IBISBA)Nederlandse Organisatie voor Wetenschappelijk Onderzoek GSGT.2019.028
6 · The paper itself

Abstract

backgroundPseudomonas putida has received increasing interest as a cell factory due to its remarkable features such as fast growth, a versatile and robust metabolism, an extensive genetic toolbox and its high tolerance to oxidative stress and toxic compounds. This interest is driven by the need to improve microbial performance to a level that enables biologically possible processes to become economically feasible, thereby fostering the transition from an oil-based economy to a more sustainable bio-based one. To this end, one of the current strategies is to maximize the product-substrate yield of an aerobic biocatalyst such as P. putida during growth on glycolytic carbon sources, such as glycerol and xylose. We demonstrate that this can be achieved by implementing the phosphoketolase shunt, through which pyruvate decarboxylation is prevented, and thus carbon loss is minimized.

resultsIn this study, we introduced the phosphoketolase shunt in the metabolism of P. putida KT2440. To maximize the effect of this pathway, we first tested and selected a phosphoketolase (Xfpk) enzyme with high activity in P. putida. Results of the enzymatic assays revealed that the most efficient Xfpk was the one isolated from Bifidobacterium breve. Using this enzyme, we improved the P. putida growth rate on glycerol and xylose by 44 and 167%, respectively, as well as the biomass yield quantified by OD

conclusionsPseudomonas putida with the implemented Xfpk shunt grew faster, reached a higher final OD

Indexed as

Pseudomonas putidaAldehyde-LyasesCarbonGlycerolMevalonic AcidNaphthoquinonesPyruvatesXyloseAldehyde-LyasesCarbonflaviolinGlycerolMevalonic AcidNaphthoquinonesphosphoketolasePyruvatesXylose

Identifiers

PMID36658566
PMCPMC9850600
OpenAlexW4317388443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.